ConAgra Brands 
CAG , maker of Marie Callender's, Healthy Choice, Birds Eye, Orville Redenbacher's, Slim Jim, and many more, has seen a continuous drop in share price since the rise of interest rates, inflation, and tariffs. The stock is currently trading near its book value of $18.71 and has a dividend yield of 6.9%. Debt-to-equity is reasonable (0.9x), but the company does have a Quick Ratio of 0.2x (short-term liquidity issues) and a Altman's Z Score (bankruptcy risk) of 1.7, which should ideally be 3+. Like almost every large-scale food company, earnings growth is relatively low, but 2025 is anticipated to be its worst performing year - which explains the price.
While the stock is not likely to generate triple-digit returns in the near-term,CAG is a strong company with a nice dividend and some growth ahead. I foresee such stocks getting new life with drops interest rates. However, a dip near $17 (into my "crash" simple moving average area) or even slightly lower is possible - which may likely result in another stock entry.
Thus, at $19.38,CAG is in a personal buy-zone with future entries planed near $17 or below.
Targets into 2028
CAG , maker of Marie Callender's, Healthy Choice, Birds Eye, Orville Redenbacher's, Slim Jim, and many more, has seen a continuous drop in share price since the rise of interest rates, inflation, and tariffs. The stock is currently trading near its book value of $18.71 and has a dividend yield of 6.9%. Debt-to-equity is reasonable (0.9x), but the company does have a Quick Ratio of 0.2x (short-term liquidity issues) and a Altman's Z Score (bankruptcy risk) of 1.7, which should ideally be 3+. Like almost every large-scale food company, earnings growth is relatively low, but 2025 is anticipated to be its worst performing year - which explains the price.While the stock is not likely to generate triple-digit returns in the near-term,
CAG is a strong company with a nice dividend and some growth ahead. I foresee such stocks getting new life with drops interest rates. However, a dip near $17 (into my "crash" simple moving average area) or even slightly lower is possible - which may likely result in another stock entry. Thus, at $19.38,
CAG is in a personal buy-zone with future entries planed near $17 or below.Targets into 2028
- $22.00 (+$13.5%)
- $25.00 (+29.0%)
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。